Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

被引:1334
作者
Kim, Seung Tae [1 ]
Cristescu, Razvan [2 ]
Bass, Adam J. [3 ]
Kim, Kyoung-Mee [4 ]
Odegaard, Justin, I [5 ]
Kim, Kyung [1 ]
Liu, Xiao Qiao [2 ]
Sher, Xinwei [2 ]
Jung, Hun [2 ]
Lee, Mijin [1 ]
Lee, Sujin [1 ]
Park, Se Hoon [1 ]
Park, Joon Oh [1 ]
Park, Young Suk [1 ]
Lim, Ho Yeong [1 ]
Lee, Hyuk [6 ]
Choi, Mingew [7 ]
Talasaz, Amirali [5 ]
Kang, Peter Soonmo [2 ]
Cheng, Jonathan [2 ]
Loboda, Andrey [2 ]
Lee, Jeeyun [1 ]
Kang, Won Ki [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea
[2] Merck & Co Inc, Kenilworth, NJ USA
[3] Dana Farber Canc Inst, Div Mol & Cellular Oncol, Boston, MA 02115 USA
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[5] Guardant Hlth, Dept Med Affairs, Redwood City, CA USA
[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Gastroenterol,Dept Med, Seoul, South Korea
[7] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea
关键词
MUTATIONAL PROCESSES; CARCINOMA; SIGNATURES; NIVOLUMAB; RECURRENT;
D O I
10.1038/s41591-018-0101-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Clinical studies support the efficacy of programmed cell death 1 (PD-1) targeted therapy in a subset of patients with metastatic gastric cancer (mGC). With the goal of identifying determinants of response, we performed molecular characterization of tissues and circulating tumor DNA (ctDNA) from 61 patients with mGC who were treated with pembrolizumab as salvage treatment in a prospective phase 2 clinical trial. In patients with microsatellite instability-high and Epstein-Barr virus-positive tumors, which are mutually exclusive, dramatic responses to pembrolizumab were observed (overall response rate (ORR) 85.7% in microsatellite instability-high mGC and ORR 100% in Epstein-Barr virus-positive mGC). For the 55 patients for whom programmed death-ligand 1 (PD-L1) combined positive score positivity was available (combined positive score cut-off value >= 1%), ORR was significantly higher in PD-L1(+) gastric cancer when compared to PD-L1(-) tumors (50.0% versus 0.0%, P value <0.001). Changes in ctDNA levels at six weeks post-treatment predicted response and progression-free survival, and decreased ctDNA was associated with improved outcomes. Our findings provide insight into the molecular features associated with response to pembrolizumab in patients with mGC and provide biomarkers potentially relevant for the selection of patients who may derive greater benefit from PD-1 inhibition.
引用
收藏
页码:1449 / +
页数:12
相关论文
共 36 条
[1]   Signatures of mutational processes in human cancer [J].
Alexandrov, Ludmil B. ;
Nik-Zainal, Serena ;
Wedge, David C. ;
Aparicio, Samuel A. J. R. ;
Behjati, Sam ;
Biankin, Andrew V. ;
Bignell, Graham R. ;
Bolli, Niccolo ;
Borg, Ake ;
Borresen-Dale, Anne-Lise ;
Boyault, Sandrine ;
Burkhardt, Birgit ;
Butler, Adam P. ;
Caldas, Carlos ;
Davies, Helen R. ;
Desmedt, Christine ;
Eils, Roland ;
Eyfjord, Jorunn Erla ;
Foekens, John A. ;
Greaves, Mel ;
Hosoda, Fumie ;
Hutter, Barbara ;
Ilicic, Tomislav ;
Imbeaud, Sandrine ;
Imielinsk, Marcin ;
Jaeger, Natalie ;
Jones, David T. W. ;
Jones, David ;
Knappskog, Stian ;
Kool, Marcel ;
Lakhani, Sunil R. ;
Lopez-Otin, Carlos ;
Martin, Sancha ;
Munshi, Nikhil C. ;
Nakamura, Hiromi ;
Northcott, Paul A. ;
Pajic, Marina ;
Papaemmanuil, Elli ;
Paradiso, Angelo ;
Pearson, John V. ;
Puente, Xose S. ;
Raine, Keiran ;
Ramakrishna, Manasa ;
Richardson, Andrea L. ;
Richter, Julia ;
Rosenstiel, Philip ;
Schlesner, Matthias ;
Schumacher, Ton N. ;
Span, Paul N. ;
Teague, Jon W. .
NATURE, 2013, 500 (7463) :415-+
[2]  
[Anonymous], 2018, INTERPRETATION MANUA, V2018
[3]   Comprehensive molecular characterization of gastric adenocarcinoma [J].
Bass, Adam J. ;
Thorsson, Vesteinn ;
Shmulevich, Ilya ;
Reynolds, Sheila M. ;
Miller, Michael ;
Bernard, Brady ;
Hinoue, Toshinori ;
Laird, Peter W. ;
Curtis, Christina ;
Shen, Hui ;
Weisenberger, Daniel J. ;
Schultz, Nikolaus ;
Shen, Ronglai ;
Weinhold, Nils ;
Keiser, David P. ;
Bowlby, Reanne ;
Sipahimalani, Payal ;
Cherniack, Andrew D. ;
Getz, Gad ;
Liu, Yingchun ;
Noble, Michael S. ;
Pedamallu, Chandra ;
Sougnez, Carrie ;
Taylor-Weiner, Amaro ;
Akbani, Rehan ;
Lee, Ju-Seog ;
Liu, Wenbin ;
Mills, Gordon B. ;
Yang, Da ;
Zhang, Wei ;
Pantazi, Angeliki ;
Parfenov, Michael ;
Gulley, Margaret ;
Piazuelo, M. Blanca ;
Schneider, Barbara G. ;
Kim, Jihun ;
Boussioutas, Alex ;
Sheth, Margi ;
Demchok, John A. ;
Rabkin, Charles S. ;
Willis, Joseph E. ;
Ng, Sam ;
Garman, Katherine ;
Beer, David G. ;
Pennathur, Arjun ;
Raphael, Benjamin J. ;
Wu, Hsin-Ta ;
Odze, Robert ;
Kim, Hark K. ;
Bowen, Jay .
NATURE, 2014, 513 (7517) :202-209
[4]   First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer [J].
Carbone, D. P. ;
Reck, M. ;
Paz-Ares, L. ;
Creelan, B. ;
Horn, L. ;
Steins, M. ;
Felip, E. ;
van den Heuvel, M. M. ;
Ciuleanu, T. -E. ;
Badin, F. ;
Ready, N. ;
Hiltermann, T. J. N. ;
Nair, S. ;
Juergens, R. ;
Peters, S. ;
Minenza, E. ;
Wrangle, J. M. ;
Rodriguez-Abreu, D. ;
Borghaei, H. ;
Blumenschein, G. R. ;
Villaruz, L. C. ;
Havel, L. ;
Krejci, J. ;
Corral Jaime, J. ;
Chang, H. ;
Geese, W. J. ;
Bhagavatheeswaran, P. ;
Chen, A. C. ;
Socinski, M. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (25) :2415-2426
[5]   Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability [J].
Cho, Junhun ;
Lee, Jeeyun ;
Bang, Heejin ;
Kim, Seung Tae ;
Park, Se Hoon ;
An, Ji Yeong ;
Choi, Min Gew ;
Lee, Joon Ho ;
Sohn, Tae Sung ;
Bae, Jae Moon ;
Kang, Won Ki ;
Kim, Sung ;
Kim, Kyoung-Mee .
ONCOTARGET, 2017, 8 (08) :13320-13328
[6]   Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples [J].
Cibulskis, Kristian ;
Lawrence, Michael S. ;
Carter, Scott L. ;
Sivachenko, Andrey ;
Jaffe, David ;
Sougnez, Carrie ;
Gabriel, Stacey ;
Meyerson, Matthew ;
Lander, Eric S. ;
Getz, Gad .
NATURE BIOTECHNOLOGY, 2013, 31 (03) :213-219
[7]   Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling [J].
Coppola, Domenico ;
Nebozhyn, Michael ;
Khalil, Farah ;
Dai, Hongyue ;
Yeatman, Timothy ;
Loboda, Andrey ;
Mule, James J. .
AMERICAN JOURNAL OF PATHOLOGY, 2011, 179 (01) :37-45
[8]   Mutational load (ML) and T-cell-inflamed microenvironment as predictors of response to pembrolizumab. [J].
Cristescu, Razvan ;
Mogg, Robin ;
Ayers, Mark ;
Albright, Andrew ;
Murphy, Erin ;
Yearley, Jennifer ;
Sher, Xinwei ;
Liu, Xiaoqiao ;
Nebozhyn, Michael ;
Lunceford, Jared K. ;
Joe, Andrew K. ;
Cheng, Jonathan ;
Plimack, Elizabeth R. ;
Ott, Patrick Alexander ;
Seiwert, Tanguy Y. ;
McClanahan, Terrill K. ;
Loboda, Andrey ;
Kaufman, David Ross .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
[9]   Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes [J].
Cristescu, Razvan ;
Lee, Jeeyun ;
Nebozhyn, Michael ;
Kim, Kyoung-Mee ;
Ting, Jason C. ;
Wong, Swee Seong ;
Liu, Jiangang ;
Yue, Yong Gang ;
Wang, Jian ;
Yu, Kun ;
Ye, Xiang S. ;
Do, In-Gu ;
Liu, Shawn ;
Gong, Lara ;
Fu, Jake ;
Jin, Jason Gang ;
Choi, Min Gew ;
Sohn, Tae Sung ;
Lee, Joon Ho ;
Bae, Jae Moon ;
Kim, Seung Tae ;
Park, Se Hoon ;
Sohn, Insuk ;
Jung, Sin-Ho ;
Tan, Patrick ;
Chen, Ronghua ;
Hardwick, James ;
Kang, Won Ki ;
Ayers, Mark ;
Dai Hongyue ;
Reinhard, Christoph ;
Loboda, Andrey ;
Kim, Sung ;
Aggarwal, Amit .
NATURE MEDICINE, 2015, 21 (05) :449-U217
[10]   Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers [J].
Derks, Sarah ;
Liao, Xiaoyun ;
Chiaravalli, Anna M. ;
Xu, Xinsen ;
Camargo, M. Constanza ;
Solcia, Enrico ;
Sessa, Fausto ;
Fleitas, Tania ;
Freeman, Gordon J. ;
Rodig, Scott J. ;
Rabkin, Charles S. ;
Bass, Adam J. .
ONCOTARGET, 2016, 7 (22) :32925-32932